MARVELGENT
Live / Registered — Registered (as of 07 Apr 2026)
What this means for you
Registered since 07 Apr 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 07 Apr 2032: the §8 declaration of use).
Record
- Serial number
- 99367386
- Registration number
- 8203664
- Mark type
- Word mark
- Filed
- 31 Aug 2025
- Published for opposition
- 17 Feb 2026
- Registered
- 07 Apr 2026
- Next maintenance filing
- §8 declaration of use, due by 07 Apr 2032 (grace period to 07 Oct 2032)
- Attorney of record
- Eunyoung Lee
Goods and services
- Class 001 — Chemicals: Antibody reagents used for the detection of antigens in cells and tissue, other than for medical or veterinary purposes; Biochemicals, namely, polypeptides for in vitro research use; Cell culture reagents for scientific or research purposes; Chemical reagents for use in genetic research; Chemicals for use in the purification of proteins for in vitro use; Chromatography chemicals; Chromatography separation media for separation of a mixture into components; Electrophoresis gels
Owner
- Marvelgent Biosciences Incorporated, Belmont, MA, US
- Marvelgent Biosciences Incorporated, Belmont, MA, US
- Marvelgent Biosciences Incorporated, Belmont, MA, US
Prosecution history
- 07 Apr 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 07 Apr 2026 — REGISTERED-PRINCIPAL REGISTER
- 17 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Feb 2026 — PUBLISHED FOR OPPOSITION
- 11 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 21 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 21 Jan 2026 — ASSIGNED TO EXAMINER
- 20 Jan 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 31 Aug 2025 — APPLICATION FILING RECEIPT MAILED
- 31 Aug 2025 — NEW APPLICATION ENTERED